ATE267400T1 - Methylorange verwendende spezifische bindungsassays - Google Patents

Methylorange verwendende spezifische bindungsassays

Info

Publication number
ATE267400T1
ATE267400T1 AT99304848T AT99304848T ATE267400T1 AT E267400 T1 ATE267400 T1 AT E267400T1 AT 99304848 T AT99304848 T AT 99304848T AT 99304848 T AT99304848 T AT 99304848T AT E267400 T1 ATE267400 T1 AT E267400T1
Authority
AT
Austria
Prior art keywords
hepatitis
virus
solid phase
antibodies
methyl orange
Prior art date
Application number
AT99304848T
Other languages
English (en)
Inventor
Pratul Unadkat
Original Assignee
Ortho Clinical Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics filed Critical Ortho Clinical Diagnostics
Application granted granted Critical
Publication of ATE267400T1 publication Critical patent/ATE267400T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99304848T 1998-06-22 1999-06-21 Methylorange verwendende spezifische bindungsassays ATE267400T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9813450A GB2339018B (en) 1998-06-22 1998-06-22 Specific binding assays using methyl orange

Publications (1)

Publication Number Publication Date
ATE267400T1 true ATE267400T1 (de) 2004-06-15

Family

ID=10834176

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99304848T ATE267400T1 (de) 1998-06-22 1999-06-21 Methylorange verwendende spezifische bindungsassays

Country Status (9)

Country Link
US (1) US6251584B1 (de)
EP (1) EP0967485B1 (de)
JP (1) JP3540675B2 (de)
AT (1) ATE267400T1 (de)
CA (1) CA2275844C (de)
DE (1) DE69917378T2 (de)
DK (1) DK0967485T3 (de)
ES (1) ES2220006T3 (de)
GB (1) GB2339018B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006081701A1 (fr) * 2005-02-02 2006-08-10 Peng Cui Kit de detection de l'anticorps du vhc et procede de preparation de celui-ci
EP2970947A4 (de) 2013-03-14 2016-10-12 Abbott Lab Rekombinante hcv-ns3-antigene und mutanten für den verbesserten nachweis von antikörpern
JP6505076B2 (ja) 2013-03-14 2019-04-24 アボット・ラボラトリーズAbbott Laboratories Hcv抗原−抗体組み合わせアッセイおよびこれに使用するための方法および組成物
CN105378099B (zh) 2013-03-14 2021-05-11 雅培制药有限公司 Hcv核心脂质结合结构域单克隆抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0324008A4 (en) * 1987-07-06 1990-11-22 Cytrx Biopool Ltd. A color-coded solid phase analysis method
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5447838A (en) * 1992-08-05 1995-09-05 Hybritech Incorporated Protein-dye conjugate for confirmation of correct dilution of calibrators
US5705330A (en) 1995-04-14 1998-01-06 Abbott Laboratories Chemiluminescent immunoassay for antibody detection
ZA97248B (en) 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques

Also Published As

Publication number Publication date
ES2220006T3 (es) 2004-12-01
CA2275844A1 (en) 1999-12-22
JP3540675B2 (ja) 2004-07-07
DK0967485T3 (da) 2004-08-16
EP0967485A3 (de) 2000-04-26
US6251584B1 (en) 2001-06-26
CA2275844C (en) 2008-11-18
DE69917378T2 (de) 2005-07-14
DE69917378D1 (de) 2004-06-24
GB2339018B (en) 2003-07-30
GB9813450D0 (en) 1998-08-19
EP0967485B1 (de) 2004-05-19
JP2000074921A (ja) 2000-03-14
EP0967485A2 (de) 1999-12-29
GB2339018A (en) 2000-01-12

Similar Documents

Publication Publication Date Title
ATE221997T1 (de) Immunoassays zum nachweis von antiphospholipid- antikörpern
ATE459885T1 (de) Verfahren zur besserung der wiederfindung troponin i und t
EP0399184A3 (de) Reagenzien, Verfahren und Testsätze zum Nachweis von Amphetaminen durch einen Fluoreszenz-Polarisations-Immunoassay
ATE99060T1 (de) Testverfahren und reagenzsatz dazu.
DK1042508T3 (da) Fremgangsmåder til forbedrede luminescensassays under anvendelse af mikropartikler
ATE80735T1 (de) Kolorimetrisches immunoessay auf fester oberflaeche, sowie dazu zu verwendender teststab und seine herstellung.
DE59409947D1 (de) Verringerung des Hook-Effekts in Immuntests mit teilchenförmigem Trägermaterial
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ATE235684T1 (de) Sensitivitätssteigerung bei der immunchemischen bestimmung eines analyten
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
DK516387D0 (da) Fremgangsmaade til immunometrisk bestemmelse
EP1138781A3 (de) Methode zur Quantifizierung der Bindeaktivität von DNA-bindenden Proteinen
SE9502024D0 (sv) Pathogen assay method
DE69917378D1 (de) Methylorange verwendende spezifische bindungsassays
ATE177208T1 (de) Nichttrennender chemilumineszenzassay durch spezifische bindung
FR2598514B1 (fr) Procede de dosage immunologique des hormones thyroidiennes t3 et/ou t4 utilisant la thyroglobuline
ATE323286T1 (de) Verfahren zum bestimmen von autoantikörpern
NO954979L (no) Fremgangsmåte til sandwich immunoassay for N-peptid
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
EA200100287A1 (ru) Высокоаффинные антитела
KR900003630A (ko) 2-부위 확인 분석방법
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
KR910021586A (ko) 리간드의 면역학적 검출방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0967485

Country of ref document: EP